bioMérieux S.A.
$8.30+0.00%(+$0.00)
TickerSpark Score
62/100
84
Valuation
85
Profitability
15
Growth
96
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMXXY research report →
52-Week Range5% of range
Low $7.95
Current $8.30
High $14.62
Companywww.biomerieux.com
bioMérieux S. A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
- CEO
- Pierre Boulud
- IPO
- 2023
- Employees
- 14,147
- HQ
- Marcy l'Étoile, FR
Price Chart
-35.91% · this period
Valuation
- Market Cap
- $9.79B
- P/E
- 21.54
- P/S
- 2.11
- P/B
- 2.09
- EV/EBITDA
- 8.89
- Div Yield
- 1.24%
Profitability
- Gross Margin
- 53.07%
- Op Margin
- 9.54%
- Net Margin
- 9.76%
- ROE
- 9.89%
- ROIC
- 6.32%
Growth & Income
- Revenue
- $3.91B · -1.78%
- Net Income
- $381.81M · -11.66%
- EPS
- $0.32 · -11.99%
- Op Income
- $539.05M
- FCF YoY
- 35.34%
Performance & Tape
- 52W High
- $14.62
- 52W Low
- $7.95
- 50D MA
- $10.46
- 200D MA
- $13.22
- Beta
- 0.54
- Avg Volume
- 1.72K
Get TickerSpark's AI analysis on BMXXY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BMXXY Coverage
We haven't published any research on BMXXY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BMXXY Report →Similar Companies
WXXWY+1.17%
WuXi Biologics (Cayman) Inc.
$8.40
SAUHF-2.02%
Straumann Holding AG
$108.49
WXIBF+0.00%
WuXi Biologics (Cayman) Inc.
$4.18
GIKLY+0.00%
Grifols, S.A.
$5.30
SAUHY+2.52%
Straumann Holding AG
$11.16
SBHMY+0.00%
Sino Biopharmaceutical Limited
$14.29
GNMSF+1.59%
Genmab A/S
$269.50
ALPMY-0.16%
Astellas Pharma Inc.
$14.54